Henderson Group »

Ovid Therapeutics shares owned by Henderson Group

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Henderson Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $24M 11M 2.22

More positions owned by Henderson Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Astrazeneca Ord (AZN)
Mastercard Incorporated Cl A (MA)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)
Argenx Se Sponsored Adr (ARGX)
Kla Corp Com New (KLAC)

View all positions for Henderson Group

Top funds holding Ovid Therapeutics

RA Capital Management
Henderson Group
Affinity Asset Advisors
Balyasny Asset Management
Vanguard Capital Management
ADAR1 Capital Management
Eventide Asset Management
Federated Investors
Adage Capital Partners GP
Vanguard Group
Ikarian Capital
Ally Bridge Group
Saturn V Capital Management
Sphera Funds Management
BlackRock

View all funds holding Ovid Therapeutics